Workflow
Molecular tests
icon
Search documents
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
Globenewswire· 2025-10-27 20:15
Core Viewpoint - Myriad Genetics, Inc. will hold its third quarter 2025 earnings conference call on November 3, 2025, at 4:30 pm ET, with earnings released after market close on the same day [1]. Company Overview - Myriad Genetics is a leader in molecular diagnostic testing and precision medicine, focusing on advancing health and well-being through molecular tests that assess disease risk and guide treatment decisions [3]. Conference Call Details - The conference call will provide a financial overview and business update regarding the company's performance for the third quarter of 2025 [1]. - A live webcast of the conference call will be available on Myriad's Investor Relations website, and an archived version will be accessible after the call [2].
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Globenewswire· 2025-08-27 20:05
Company Overview - Myriad Genetics, Inc. is a leader in molecular diagnostic testing and precision medicine, focusing on advancing health and well-being for all [3] - The company develops molecular tests that assess disease risk and guide treatment decisions, aiming to improve patient care and reduce healthcare costs [3] Upcoming Events - Myriad management will participate in two healthcare conferences: the Wells Fargo Healthcare Conference on September 4 at 3:45 PM ET and the Morgan Stanley Annual Global Healthcare Conference on September 10 at 7:45 AM ET [1][4] - Live and archived webcasts of both presentations will be available at investor.myriad.com [2]
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
Globenewswire· 2025-07-29 20:05
Core Points - Myriad Genetics, Inc. will hold its second quarter 2025 earnings conference call on August 5, 2025, at 4:30 PM ET [1] - The company's quarterly earnings will be released the same day after market close [1] - Management will provide a financial overview and business update during the call [1] Company Overview - Myriad Genetics is a leader in molecular diagnostic testing and precision medicine [3] - The company develops molecular tests that assess disease risk and guide treatment decisions, aiming to improve patient care and reduce healthcare costs [3] Investor Information - A live webcast of the conference call will be available on Myriad's Investor Relations website [2] - Participants can register for the call to receive a dial-in number and unique PIN [2] - An archived version of the webcast will be accessible after the call [2]